Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis. Plazomicin has had limited clinical use but has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent liver injury. It is grouped under the following drug class(es): Aminoglycosides. Its therapeutic use is listed as anti-infectives and antibiotics. The directory classifies it as a discontinued API with a semi-synthetic source/manufacturing origin. Other names for this substance include plazomicina and plazomicine. Its PubChem CID is 42613186.
Plazomicin
| CAS No | 1154757-24-0 |
|---|---|
| Molecular Formula | C25H48N6O10 |
| Molecular Weight | 592.7 g/mol |
| Synonyms | (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.
The listed CAS number is 1154757-24-0.
The listed molecular formula is C25H48N6O10.
The listed molecular weight is 592.7 g/mol.
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide.
The source lists plazomicina and plazomicine.